Swiss government funds four new Covid treatment drugs
Four Swiss-based companies will received state funding to develop a range of new drugs to treat coronavirus, which are expected to be available by the end of 2022.
This content was published on
1 minute
swissinfo.ch/dos
Português
pt
Governo suíço financia quatro novos medicamentos contra a Covid
The contracts were signed in the context of the Federal Funding Programme for Covid-19 Medicines, run by the Federal Office for Public Health (FOPH) and the Swiss Innovation Agency Innosuisse, the government said on MondayExternal link.
The total value of the four deals is CHF27 million ($29.2 million).
The projects aim to treat a range of the symptoms caused by a Covid-19 infection and to mitigate the length and severity of illness.
Two of the drugs are monoclonal antibody treatments: one for the neuropsychiatric symptoms in sufferers of long Covid, and the other for use on patients at risk of a severe course of Covid-19. A third project is developing an oral pulmonary vasodilator which makers hope will prevent respiratory failure and reduce the need for artificial ventilation.
A final project is an antiviral and anti-inflammatory to treat “all severities of Covid-19”.
Switzerland will enjoy “certain benefits” in return for its investment, the government stated. This includes having a first option on purchases of the drugs.
The government’s medical procurement capabilities to tackle the coronavirus pandemic come under the remit of the Covid-19 law, approved for a second time by voters in a nationwide referendum two weeks ago.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
First large-scale alpine solar plant approved in Switzerland
This content was published on
The approval was met with satisfaction by the project's organisers, but it also brings with it a certain amount of pressure.
Medieval squirrels may have ‘helped spread leprosy’
This content was published on
An examination of squirrel remains in the United Kingdom has opened up interesting questions and possibilities in terms of the history of the disease.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
It’s not all about age: why Covid hits some people harder than others
This content was published on
New insights: two studies involving Swiss scientists suggest genes and blood sugar levels play a crucial role in the course of Covid-19.
This content was published on
Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.